[EN] INHIBITORS OF MOLLUSCUM CONTAGIOSUM INFECTION AND METHODS USING THE SAME [FR] INHIBITEURS DE L'INFECTION PAR LE MOLLUSCUM CONTAGIOSUM ET MÉTHODES LES UTILISANT
摘要:
The present invention provides novel compounds, compositions and methods for treating, ameliorating, and/or preventing an orthopoxvirus infection in a subject in need thereof. In certain embodiments, the orthopoxvirus infection is caused byMolluscum contagiosum.
[EN] INHIBITORS OF MOLLUSCUM CONTAGIOSUM INFECTION AND METHODS USING THE SAME [FR] INHIBITEURS DE L'INFECTION PAR LE MOLLUSCUM CONTAGIOSUM ET MÉTHODES LES UTILISANT
摘要:
The present invention provides novel compounds, compositions and methods for treating, ameliorating, and/or preventing an orthopoxvirus infection in a subject in need thereof. In certain embodiments, the orthopoxvirus infection is caused byMolluscum contagiosum.
[EN] NOVEL AMINO ACID DERIVATIVES AND THEIR USE AS GPR43 RECEPTOR MODULATORS<br/>[FR] NOUVEAUX DÉRIVÉS D'ACIDE AMINÉ ET LEUR UTILISATION EN TANT QUE MODULATEURS DU RÉCEPTEUR GPR43
申请人:EUROSCREEN SA
公开号:WO2011092284A1
公开(公告)日:2011-08-04
The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing inflammatory, gastrointestinal and/or metabolic disorders.
本发明涉及化合物(I)的新型化合物及其在治疗和/或预防炎症、胃肠道和/或代谢性疾病中的应用。
Organocatalytic enantioselective decarboxylative protonation of α-alkyl-α-aryl malonate monoesters
enzymatic enantioselectivedecarboxylative protonation (EDP), the corresponding chemocatalytic reactions of acyclic malonic acid derivatives remain challenging. Herein, we developed a biomimetic EDP of α-alkyl-α-aryl malonate monoesters using a chiral 1,2-trans-diaminocyclohexane-based N-sulfonamide as an organocatalyst. The method demonstrates excellent chemical yields, good enantioselectivity, mild reaction
SUBSTITUIERTE 3-PHENYLPROPIONSÄUREN UND IHRE VERWENDUNG
申请人:Bayer Pharma Aktiengesellschaft
公开号:EP2493845A1
公开(公告)日:2012-09-05
[DE] SUBSTITUIERTE 3-PHENYLPROPIONSÄUREN UND IHRE VERWENDUNG<br/>[EN] SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF<br/>[FR] ACIDES 3-PHÉNYLPROPIONIQUES SUBSTITUÉS ET LEUR UTILISATION
申请人:BAYER SCHERING PHARMA AG
公开号:WO2011051165A1
公开(公告)日:2011-05-05
Die vorliegende Anmeldung betrifft neue 3-Phenylpropionsäure-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung zur Behandlung und/oder Prävention von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prävention von Krankheiten, insbesondere zur Behandlung und/oder Prävention kardiovaskulärer Erkrankungen.